Israeli study: Pfizer coronavirus vaccine is 91 percent effective at preventing infection

A joint study with Israeli HMO Maccabi and the Technion, which included data from 1.7 million Israelis, shows protection against coronavirus peaks 35 days after second jab, at 99.3 percent